503b glp-1 Navigating Access: The Future of Compounded Receptor Agonists for Weight Loss FDA moves to exclude three

Important considerations include: Individual responses vary considerablynot all patients experience reduced cravings Changes in food preferences may reflect general appetite suppression rather than specific effects on sugar craving Psychological and behavioural factors continue to influence eating patterns Long-term sustainability of any craving reduction after medication discontinuation is uncertain Patients should not rely solely on medication to manage sugar intake

Natural methods work gradually, typically showing results over weeks to months, making consistency important for the best outcome

(2022) (Wen et al

Acknowledgements We would like to thank Qiulin Tang for her assistance in preparing the manuscript